anro: the income statement

MyFinsight

Alto Neuroscience, Inc. (ANRO)

For the quarter ending 2025-06-30, ANRO made $1,683K in revenue. -$17,706K in net income. Net profit margin of -1052.05%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Research and development	13,124
General and administrative	5,558
Total operating expenses	18,682
Loss from operations	-18,682
Interest income	1,683
Interest expense	646
Loss on debt extinguishment	-
Other, net	61
Total other income, net	976
Net loss	-17,706

Net loss per share attributable to common stockholders, basic (in dollars per share)	-0.65
Net loss per share attributable to common stockholders, diluted (in dollars per share)	-0.65
Weighted-average number of common shares outstanding, basic (in shares)	27,072,000
Weighted-average number of common shares outstanding, diluted (in shares)	27,072,000

Unit: Thousand (K) dollars (except for numbers of shares and EPS)